Mayo, Hadar B.

HRN: 09-72-55  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/19/2023
04/26/2023
IV
1.5g
Q8H
Aspiration Pneumonia, Lacerated Wound, Post Auricular Area, R
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: